Wenzel, Richard P.

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases

Nosocomial Infections in ICUInfection Control in Healthcare

Cited by 4,496

Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis

Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases

Antimicrobial Resistance in StaphylococcusInfection Control in Healthcare

Cited by 1,387

Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States

Wisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2003) · Clinical Infectious Diseases

Neutropenia and Cancer InfectionsInfection Control in Healthcare

Cited by 687

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Blumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityNosocomial Infections in ICU

Cited by 661

Risk factors for candidemia in Neonatal Intensive Care Unit patients

SAIMAN, L., LUDINGTON, E., PFALLER, M., RANGEL-FRAUSTO, S., WIBLIN, T. R., DAWSON, J., BLUMBERG, H. M., PATTERSON, J. E., RINALDI, M., EDWARDS, J. E., et al. (2000) · The Pediatric Infectious Disease Journal

Antifungal resistance and susceptibilityNeonatal and Maternal Infections

Cited by 587

Nosocomial Candidemia: Risk Factors and Attributable Mortality

Wenzel, R. P. (1995) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 502

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 424

Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities

Wisplinghoff, H., Ebbers, J., Geurtz, L., Stefanik, D., Major, Y., Edmond, M. B., Wenzel, R. P., & Seifert, H. (2014) · International Journal of Antimicrobial Agents

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 293

National Epidemiology of Mycoses Survey: A Multicenter Study of Strain Variation and Antifungal Susceptibility Among Isolates of Candida Species

Pfaller, M. A., Messer, S. A., Houston, A., Rangel-Frausto, M. S., Wiblin, T., Blumberg, H. M., Edwards, J. E., Jarvis, W., Martin, M. A., Neu, H. C., et al. (1998) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 141

Patient characteristics and admitting vital signs associated with coronavirus disease 2019 (COVID-19)–related mortality among patients admitted with noncritical illness

Sands, K. E., Wenzel, R. P., McLean, L. E., Korwek, K. M., Roach, J. D., Miller, K. M., Poland, R. E., Burgess, L. H., Jackson, E. S., & Perlin, J. B. (2021) · Infection Control & Hospital Epidemiology

COVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts

Cited by 29

Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents

Pfaller, M. A., Wey, S., Gerarden, T., Houston, A., & Wenzel, R. P. (1989) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 18